Keywords: bayer, stops, non-cabg, trasylol, studies, german, drugmaker

Bayer stops non-CABG Trasylol studies

Article | 05 February 2007

Print This

German drugmaker Bayer says that it has stopped trials of its product Trasylol (aprotinin injection) in non-coronary artery bypass graft ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in